Global Arginine Market Sees Mid-August Weakness as Downstream Demand Softens

Global Arginine Market Sees Mid-August Weakness as Downstream Demand Softens

Gabreilla Figueroa 18-Aug-2025

The global L-Arginine market witnessed a downtrend in the first half of August 2025 as weak demand from pharmaceuticals, nutraceuticals, and food & beverage sectors weighed on consumption. Buyers, holding sufficient inventory from earlier procurements, adopted a cautious approach and avoided bulk purchases. Meanwhile, uninterrupted production ensured steady availability, creating a supply-demand imbalance. Seasonal stabilization in consumer demand for dietary supplements also contributed to the slowdown. Looking ahead, the market is expected to remain steady with only marginal shifts as procurement gradually resumes.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.